Xianhui Huang

Find an error

Name:
Organization: South China Agricultural University
Department: College of Veterinary Medicine, National Reference Laboratory of Veterinary Drug Residues (SCAU)
Title:
Co-reporter:Hui Wang, Bo Yuan, Zhenling Zeng, Limin He, Huanzhong Ding, Chunna Guo, Xiangkai Kong, Wei Wang, Xianhui Huang
Journal of Chromatography B 2014 Volume 965() pp:91-99
Publication Date(Web):15 August 2014
DOI:10.1016/j.jchromb.2014.06.010
•This novel study investigated in vivo diaveridine metabolism in chickens.•Nine phase I and six phase II metabolites were identified in total.•Ten new metabolites were identified compared to previous in vitro studies in pigs.•The major phase I metabolites were O-demethylation and N-oxidation derivatives.•The major phase II metabolites were glucuronide conjugates.Diaveridine (DVD) is a popular antibacterial synergist that is widely used in combination with sulfonamide. It has been reported to be genotoxic to mammalian cells, but more studies are required to clarify this. Moreover, there is very little information on its pharmacokinetics, metabolic elimination and mechanism of toxicity. Therefore, in order to gain a better understanding of the metabolism of DVD, we performed high-performance liquid chromatography linear ion trapped orbitrap mass spectrometer (LC-LTQ-Orbitrap). With this approach, we identified 15 metabolites of DVD in chicken after a single oral administration of DVD; 10 of these metabolites have been identified in vivo for the first time. Nine phase I and five phase II metabolites were detected in the plasma, and eight phase I and six phase II metabolites were found in feces. The major phase I metabolites were formed via the O-demethylation and N-oxidation pathways, and the major phase II metabolites were glucuronide conjugates. These results are essential for understanding this compound more clearly and lay the basis for further studies about the metabolism of DVD. Therefore, using this approach, we were able to identify and characterize metabolites of DVD with high sensitivity and resolution. We were able to detect a broad range of metabolites, even some trace ones and some so far unknown metabolites.
Co-reporter:Zhan-mei YU, Xian-hui HUANG, Chao-qun YAN, Jin GAO, Zi-sen LIANG
Journal of Integrative Agriculture (March 2016) Volume 15(Issue 3) pp:650-657
Publication Date(Web):1 March 2016
DOI:10.1016/S2095-3119(14)60971-0
Fuzheng Jiedu granule exhibits a number of health benefits and it is thought that the mechanisms involved in these effects are due to the modulation of immunity. In this article, we studied the effect of Fuzheng Jiedu granule on immunological function and the expression of immune-related cytokines in immune-suppressed mice. 72 mice were randomly divided into six groups, with 12 in each group. The control groups included an untreated group, a negative control group (Cyclophosphamide) and a positive control group (Astragalus polysaccharide). There were three treated groups, which were given different doses of Fuzheng Jiedu granule: a low dose (100 mg kg–1), a medium dose (400 mg kg–1) and a high dose (600 mg kg–1). With the exception of the untreated control animals, each group received an intraperitoneal injection of Cyclophosphamide (100 mg kg–1) for 3 days to establish the immune-suppressed model. Mice were then treated for 19 consecutive days and, 24 h after the last treatment, blood was taken for the eyeballs and serum separation was performed. Analysis was made of the levels of related cytokines (IgA, IgG, IgM, IL-6, IFN-γ, C3, C4 and TNF-α), the transformation of lymphocytes and the immune organ indexes. The results showed that Fuzheng Jiedu granule can improve the levels of cytokines, the rate of proliferation of lymphocytes and the immune organ indexes of immune-suppressed mice.
Co-reporter:Xian-hui HUANG, Yong-da ZHAO, Li-min HE, Zi-sen LIANG, ... Bing-hu FANG
Journal of Integrative Agriculture (March 2012) Volume 11(Issue 3) pp:465-473
Publication Date(Web):1 March 2012
DOI:10.1016/S2095-3119(12)60032-X
An accurate and precise method for the determination of tulathromycin in swine plasma was developed and validated. Plasma samples were analyzed by high-performance liquid chromatography with tandem mass spectrometry detection (HPLC-MS/MS) using electrospray ionization (ESI). Tulathromycin was extracted from plasma by precipitation with acetonitrile and separated using a Phenomenex Luna 5 μm C18 column (150 mm×2.0 mm) at a flow rate of 0.25 mL min−1. Solvent A consisted of 0.002 mol L−1 ammonium acetate and formic acid (999:1, v/v), and solvent B was acetonitrile. The mass spectrometer was operated in the selected-ion mode with atmospheric pressure chemical ionization to monitor the respective MH+ ions, namely, m/z 577.3 for tulathromycin and m/z 679.3 for the internal standard roxithromycin. The calibration curves were linear in a dynamic range of 2.0-500 ng mL−1 on the column. The accuracy was ranged from 95.25 to 109.75%, and the precision was ranged from 2.81 to 7.72%. The recoveries measured at 3 concentration levels (20, 250, and 500 ng mL−1) were higher than 98%. The method described above is efficient, and has the required accuracy and precision for rapid determination of tulathromycin in plasma. The method was applied to study the pharmacokinetics of tulathromycin in swine, and tulathromycin demonstrated a rapid absorption, wide distribution, and slow elimination after intramuscular administration.
Tizoxanide Sulfate
2-Hydroxy-N-(5-nitrothiazol-2-yl)benzamide
ractopamine
5-[(4-ethoxy-3-methoxyphenyl)methyl]pyrimidine-2,4-diamine
5-[(2,4-Diamino-5-pyrimidinyl)methyl]-2-methoxyphenol
PHENOL, 4-[(2,4-DIAMINO-5-PYRIMIDINYL)METHYL]-2-METHOXY-
Benzenemethanol, 4-amino-3,5-dichloro-α-[[(1,1-dimethylethyl)amino]methyl]-
4H-Pyrano[2,3-b][1,4]benzodioxin-4-one,decahydro-4a,7,9-trihydroxy-2-methyl-6,8- bis(methylamino)-,(2R,4aR,5aR,6S,7S,8R,9S,- 9aR,10aS)-,sulfate (1:1) (salt)
5-(2-(tert-Butylamino)-1-hydroxyethyl)benzene-1,3-diol
Fenoterol